Dr. Robinson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
536 Saybrook Rd
Middletown, CT 06457Phone+1 860-358-2220Fax+1 860-358-2222
Education & Training
- Yale School of MedicineClass of 2016
Certifications & Licensure
- CT State Medical License 2020 - 2025
- CA State Medical License 2019 - 2021
- PA State Medical License 2017 - 2019
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsTreatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on Osimertinib.Nathaniel D Robinson, Maureen E Canavan, Peter L Zhan, Brooks V Udelsman, Ranjan Pathak
Clinical Lung Cancer. 2024-09-23 - 383 citations2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.Parker L. Sulkowski, Christopher D. Corso, Nathaniel D. Robinson, Susan E. Scanlon, Karin Purshouse
Science Translational Medicine. 2017-02-01 - 168 citationsActivity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoRDaniel H. Ebert, Harrison W. Gabel, Nathaniel D. Robinson, Nathaniel R. Kastan, Linda Hu
Nature. 2013-07-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: